Agfa HealthCare and Derby Teaching Hospitals NHS Foundation Trust, UK, sign agreement for ORBIS Clinical Information System
ORBIS Clinical Information System will be implemented within the Adult Critical Care and Step Down Units and integrated with medications prescribing and administration.
Mortsel, Belgium – 18 April 2016 – 14:00 CET
Main clinical workflows include:
- ORBIS ICU-Manager* - Automates the collection of patient monitoring data from medical devices in the ICU, eliminating the need for manual transcription.
- Locally definable Clinical Decision Support Rules and Knowledge Management
- Full Noting and Clinical Assessment Module
- CPOE Module – To manage requesting and reporting workflows
- eObservations – Including Early Warning Scores
- ORBIS Medication - To further support improved patient safety, quality and cost control
- Mobile Technology – To support more flexible working
ICU-Manager solution for its Adult Critical Care units. Implementation will start immediately, in a phased approach. The project was funded by the NHS England’s Integrated Digital Care Technology Fund.
Comprehensive overview of ICU
Derby Teaching Hospitals is a large NHS Foundation Trust that provides integrated healthcare services. Its two main sites, the Royal Derby Hospital and the London Road Community Hospital, together count 1,100 beds. The Adult Critical Care unit has 44 beds and includes both an Intensive Care Unit (ICU) and a Surgical High Dependency unit. The Critical Care facilities provide a variety of services to about 3,000 patients each year.
ICU environments have their own unique requirements for documentation and data capture. Poorly managed documentation can not only impact on the quality of care patients receive, but it can also prevent the unit from ensuring that it receives all of the reimbursements and revenues that it should. ORBIS ICU-Manager provides tools to efficiently manage the ICU, with a comprehensive overview of rooms, beds, patients, etc., medical and nursing documentation and a broad range of other clinical activities.
Faster workflow, less risk of error
Implementing the ORBIS ICU solution will allow Derby Teaching Hospitals to automate the collection of data from monitors and devices in the ICU, eliminating the need for manual transcription. By speeding up workflow and reducing the risk of potential errors, it can help the hospital to improve clinical safety, efficiency and cost effectiveness.
The agreement includes ORBIS Medication, which offers prescribing and administration of drugs from the patient’s admission to discharge that encompasses drug prescription with clinical decision support, drug administration, pharmaceutical validation and resupply.
ORBIS was chosen by Derby Teaching Hospitals for its innovation, flexibility and its ability to be locally configured. In addition, site-defined workflows can be created to support interfacing to bedside devices and equipment, clinical decision support, medication management, reporting and specific terminology for critical care clinical notes.
Clinical efficiency and cost effectiveness
“We are pleased that the first ORBIS implementation in the UK will support the Adult Critical Care unit of Derby Teaching Hospitals with a flexible clinical information system that meets its specific needs,” comments Grant Witheridge, Managing Director UK & Ireland, Agfa HealthCare. “This agreement underscores our strategy to help hospitals and healthcare organisations to enhance their patient care with a range of products and services that runs from Digital Radiography, Enterprise Imaging and Radiology IT, to full hospital IT and integrated care.”
“ORBIS ICU-Manager will provide us with tools to help us reach our goals of improving clinical safety, efficiency and cost effectiveness, as well as our planning and care processes,” comments Dr. Nick Reynolds LLM FRCA FICM Consultant in Anaesthesia and Intensive Care of Derby Teaching Hospitals NHS Foundation Trust, “it offers the flexibility and innovation we need to handle the specific requirements of our critical care environment.”
*ORBIS ICU-Manager is not available in the US and Canada
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,620 million euro in 2014.
About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2014 were 1,069 million euro.
For images, courtesy of Agfa HealthCare, please visit www.agfahealthcare/resources
Follow us at Twitter
Agfa, the Agfa rhombus and ORBIS are trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. All rights reserved.
All information contained herein is intended for guidance purposes only, and characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. Agfa HealthCare diligently strives to provide as accurate information as possible, but shall not be responsible for any typographical error.
Only the English version of this press release is legally valid. The versions in other languages only represent a translation of the original English version.